Chinese english Japanese Germany Korea

(-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt

(-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt Structure
CAS No.
128173-53-5
Chemical Name:
(-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt
Synonyms
Escitalopram OxalateD-DTTA;Escitalopram Related Compound;EscitalopraM Related CoMpound A;Escitalopram USP Related Compound A;Escitalopram Related Compound A D-DTTA Salt;Escitalopram USP Related Compound A as Hemi-di-toluoyltartrate;(-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3...;Escitalopram Oxalate EP Impurity E as (S)-Enantiomer Ditoluoyltartrate;4-{4-(Dimethylamino)-[(4'-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)}benzonitrile;(-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrilehemiD-(+)-
CBNumber:
CB61503922
Molecular Formula:
2C20H23FN2O2.C20H18O8
Molecular Weight:
1071.18
MOL File:
128173-53-5.mol
MSDS File:
SDS
Modify Date:
2022/12/21 16:56:50
Request For Quotation

(-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt Properties

Melting point 134-135 °C

SAFETY

Risk and Safety Statements

HS Code  2926900005

(-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt Chemical Properties,Uses,Production

Uses

(S)-4-[4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)-benzonitrile (2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]butanedioate is an impurity in the synthesis of Escitalopram (C505010), an inhibitor of serotonin (5-HT) uptake. Antidepressant.

(-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt Preparation Products And Raw materials

Raw materials

Preparation Products

(-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt Suppliers

Global( 76)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
KEVYS GROUP +91-9000001018 +91-9000001018 Telangana, India 23 58 Inquiry
Bhausa Life Sciences +91-8154986830 +91-8154986830 Gujarat, India 201 58 Inquiry
Viyash Life Sciences Pvt Ltd +91-4023635052 +91-4023635052 Telangana, India 213 58 Inquiry
Synergene Active Ingredients Pvt. Ltd. +91-04023700774 +91-04023700774 Telangana, India 96 58 Inquiry
Rivashaa Agrotech Biopharma Pvt. Ltd. +91-26463395 +91-7926462688 Gujarat, India 1615 58 Inquiry
Kekule Pharma Limited +919849798889 Hyderabad, India 59 58 Inquiry
Ralington Pharma +91-7948911722 +91-9687771722 Gujarat, India 1350 58 Inquiry
Alliance Pharma +91-9824141142 +91-9824141142 Gujarat, India 181 58 Inquiry
Lavybens Pharma +91-8790466757 +91-8790466756 Telangana, India 80 58 Inquiry
Manus Aktteva +91 (79) 6512-3395 New Delhi, India 581 34 Inquiry
Supplier Advantage
KEVYS GROUP 58
Bhausa Life Sciences 58
Viyash Life Sciences Pvt Ltd 58
Synergene Active Ingredients Pvt. Ltd. 58
Rivashaa Agrotech Biopharma Pvt. Ltd. 58
Kekule Pharma Limited 58
Ralington Pharma 58
Alliance Pharma 58
Lavybens Pharma 58
Manus Aktteva 34

128173-53-5((-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt)Related Search:

Diphenyldimethoxysilane Tris(hydroxymethyl)nitromethane Xylene Butylated Hydroxytoluene (-)-Di-p-toluoyl-L-tartaric acid
Metformin 3-Dimethylaminopropylamine 2,3-Di-O-para-toluoyl-D-tartaric acid Butylated hydroxyanisole Stearoylbenzoylmethane
4-(HYDROXYMETHYL)BENZONITRILE (-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt
chevron_left

1of3

chevron_right
(-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt (S)-4-[4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile (2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]butanedioate (2:1) Escitalopram Related Compound A (10 mg) ((-) 4-[(4-dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybutyl)]-3-(hydroxymethyl) benzonitrile) (+)-Dipara tolouyl–d-tartaric acid salt of 4-[(4'-DiMethyl aMino)-1-(4"-fluorophenyl)-1-hydroxy butyl]-3-(hydroxy Methyl) benzonitrile (S)-4-[4-(DiMethylaMino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxyMethyl)-benzonitrile (2S,3S)-2,3-bis[(4-Methylbenzoyl)oxy]butanedioate EscitalopraM Related CoMpound A Escitalopram USP Related Compound A Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2S,3S)-, compd. with 4-[(1S)-4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile (1:2) (-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybutyl)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt Escitalopram OxalateD-DTTA 4-{4-(Dimethylamino)-[(4'-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)}benzonitrile 4-((S)-4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile D-DTTA salt Escitalopram Related Compound A D-DTTA Salt (2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]butanedioic acid,4-[(1S)-4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile 4-[(4-Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)-benzonitrile D-hemi tartaricacid salt (-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrilehemiD-(+)- (-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3... 4-[(4-Dimethylamino)-1-(4-fluorophenyl)-1-Hydroxybutyl]-3-(hydroxymethyl)-benzonitile-D-hemi tartari (-)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(+)-di-p-toloyltartaric acid salt Escitalopram Related Compound A ((S)-4-[4-dimethylamino-1-(4-fluoropheny)-1-hydroxy-1-butyl]-3-hydr (1249417) (+)-4-(4-Dimethylamino)-1-(4-fluorophenyl)-1-(hydroxybuty)-3-hydroxymethyl)-benzonitrile hemi D-(-)-di-p-toloyltartaric acid salt Escitalopram USP Related Compound A as Hemi-di-toluoyltartrate Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2S,3S)-, compd. with 4-[(1S)-4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile (1:2) (9CI, ACI) (2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]-Butanedioic acid compd. with 4-[(1S)-4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile (1:2) (9CI ACI) Benzonitrile, 4-[4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)-, (S)-, (2S,3S)-2,3-bis[(4-methylbenzoyl)oxy]butanedioate (2:1) (‐)‐4‐(4‐Dimetylamino)‐1‐(4‐ fluorophenyl)‐1‐hydroxybutyl]‐ 3‐(hydroxymethyl)?benzonitrile? ,Hemi?D‐(+)‐Di‐p‐toluoyl?tartaric? acid?salt?(CTS‐I) Escitalopram Oxalate EP Impurity E as (S)-Enantiomer Ditoluoyltartrate (+)-Dipara tolouyl–d-tartaric acid salt of 4-[(4’-Dimethyl amino)-1-(4”-fluorophenyl)-1-hydroxy butyl]-3-(hydroxy methyl) benzonitrile Escitalopram Related Compound 128173-53-5 2C20H23FN2O2C20H18O8 C60H64F2N4O12